Tadayuki Kitagawa
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 14, 2024
A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations.
Journal: International journal of clinical oncology
Published: April 24, 2024
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A.
Journal: International journal of hematology
Published: March 03, 2024
Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
Journal: Neuropsychiatric disease and treatment
Published: September 27, 2021
Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
Journal: Neuropsychiatric disease and treatment
Published: September 23, 2021
Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
Journal: Neuropsychiatric disease and treatment
Published: September 23, 2021
Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.
Journal: PloS one
Published: September 02, 2020
Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
Journal: Psychiatry and clinical neurosciences
Published: June 24, 2019
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: August 23, 2018
Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan.
Journal: Parkinsonism & related disorders
Published: April 23, 2018
Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial.
Journal: Psychiatry and clinical neurosciences
Published: June 26, 2017
Last Updated: 09/26/2026